Chairman of the Egyptian Drug Authority Inspects Vitabiotics Egypt and Gelatin Factories in New Borg El Arab City El-Ghamrawy: Continued Support for Localizing Pharmaceutical Industries and Achieving Self-Sufficiency …............... Dr. Ali El-Ghamrawy, Chairman of EDA, conducted a field visit to Vitabiotics Egypt and the Arab Company for Gelatinous and Pharmaceutical Products in New Borg El Arab City, Alexandria. The tour focused on reviewing production capabilities, observing adherence to international quality standards, and encouraging investment in pharmaceutical manufacturing to enhance local capacity. Dr. El-Ghamrawy emphasized the EDA’s ongoing support for national pharmaceutical projects that contribute to self-sufficiency and reduce dependence on imports, in alignment with Egypt's Vision 2030. He commended the efforts of both companies in modernizing production lines and aligning operations with global standards, reaffirming the Authority's commitment to providing technical and regulatory support to strengthen the competitiveness of Egyptian products. Vitabiotics Egypt has developed production lines in its factory in the Borg El Arab area to gradually increase production capacity from 15 million packs to 25 million packs annually by the end of 2025, through key axes including: increasing tablet and capsule production from 132 million to 250 million units annually, raising liquid bottle production from 24 million to 33 million units annually, and increasing strip production to 50 million strips instead of the current 31 million. The Arab Company for Gelatinous and Pharmaceutical Products highlighted its role in enhancing local supply chains, with a production capacity of 2.5 billion hard capsules and 275 million soft capsules annually. The company has invested over EGP 50 million to boost production capabilities, including inhalation anesthetics, veterinary products, and contract manufacturing for 35 companies, achieving 70% growth in 2024 compared to 2023. Representatives from both companies acknowledged the EDA’s pivotal role in supporting local manufacturing and facilitating regulatory processes. They stressed that close collaboration with the Authority is vital for achieving industrial sustainability and enhancing export competitiveness. The visit was attended by senior EDA officials, including Dr. Yasin Ragaey, Dr. Amany Gawdat, Dr. Amira Mahjoub, and Dr. Osama Hatem. It reflects the Authority’s strategy to foster public-private partnerships, promote investment in advanced pharmaceutical production, and localize vital industries that support public health and economic growth. The EDA reaffirms its commitment to collaborating with strategic partners to realize Egypt’s goal of becoming a regional hub for pharmaceutical manufacturing, supporting national health priorities and contributing to long-term pharmaceutical security and self-sufficiency. #EgyptianDrugAuthority #EgyptianDrugAuthorityMediaCenter #EgyptianPharmaceuticals
